🇺🇸 FDA
Pipeline program

LCAR-BCDR cells product

BM2L202103

Phase 1 mab terminated

Quick answer

LCAR-BCDR cells product for Relapsed/Refractory Multiple Myeloma is a Phase 1 program (mab) at Legend Biotech Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
Legend Biotech Corp
Indication
Relapsed/Refractory Multiple Myeloma
Phase
Phase 1
Modality
mab
Status
terminated

Clinical trials